Berry Genomics announced that Beijing Berry Hekang Biotechnology Co., Ltd., a wholly-owned subsidiary, and Beijing Children's Hospital affiliated to Capital Medical University signed a “Project Achievement Transformation Cooperation Framework Agreement”. The two sides will promote the transformation of results on the “Research and Product Research and Development of Key Techniques for Early Screening and Early Diagnosis of Neonatal Functional Birth Defects”, jointly develop a health management system throughout the life cycle, and build a neonatal and child health database. The purpose of this cooperation is to rely on the advantages of both parties to promote the clinical promotion of genetic testing services for neonatal and pediatric genetic diseases in Party A and its partner hospitals. The company will fulfill the corresponding approval procedures and information disclosure obligations in accordance with the subsequent progress of specific cooperation matters.

Berry Genomics announced that Beijing Berry Hekang Biotechnology Co., Ltd., a wholly-owned subsidiary, and Beijing Children's Hospital affiliated to Capital Medical University signed a “Project Achievement Transformation Cooperation Framework Agreement”. The two sides will promote the transformation of results on the “Research and Product Research and Development of Key Techniques for Early Screening and Early Diagnosis of Neonatal Functional Birth Defects”, jointly develop a health management system throughout the life cycle, and build a neonatal and child health database. The purpose of this cooperation is to rely on the advantages of both parties to promote the clinical promotion of genetic testing services for neonatal and pediatric genetic diseases in Party A and its partner hospitals. The company will fulfill the corresponding approval procedures and information disclosure obligations in accordance with the subsequent progress of specific cooperation matters.